Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
The Journal of Infectious Diseases · 16.08.2024 · 230 (2) · e318-e326
DOI: 10.1093/infdis/jiae036 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 29.02.2024. Verfasst von Benedikt Strunz und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, Interferon Type I, Autoantibodies, SARS-CoV-2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, European Union Horizon 2020, Swedish Research Council.
Abstract (Originalsprache)
Background
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to severe disease with increased morbidity and mortality among certain risk groups. The presence of autoantibodies against type I interferons (aIFN-Abs) is one mechanism that contributes to severe coronavirus disease 2019 (COVID-19).
Methods
This study aimed to investigate the presence of aIFN-Abs in relation to the soluble proteome, circulating immune cell numbers, and cellular phenotypes, as well as development of adaptive immunity. Results aIFN-Abs were more prevalent in critical compared to severe COVID-19 but largely absent in the other viral and bacterial infections studied here. The antibody and T-cell response to SARS-CoV-2 remained largely unaffected by the presence aIFN-Abs. Similarly, the inflammatory response in COVID-19 was comparable in individuals with and without aIFN-Abs. Instead, presence of aIFN-Abs had an impact on cellular immune system composition and skewing of cellular immune pathways.
Conclusions
Our data suggest that aIFN-Abs do not significantly influence development of adaptive immunity but covary with alterations in immune cell numbers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Department of Immunology, Oslo University Hospital, Oslo, Norway.
- Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
- Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Benedikt Strunz, Niklas K Björkström
Förderung
- European Research Council
- European Union Horizon 2020
- Swedish Research Council
- Swedish Cancer Society
- Swedish Society for Medical Research
- Swedish Foundation for Strategic Research
- Knut and Alice Wallenberg Foundation
- Novo Nordisk Foundation
Zitieren
APA
Strunz, B., Maucourant, C., Mehta, A., Wan, H., Du, L., Sun, D., Chen, P., Nordlander, A., Gao, Y., Cornillet, M., Bister, J., Kvedaraite, E., Christ, W., Klingström, J., Geanon, D., Parke, Å., Ekwall-Larson, A., Rivino, L., MacAry, P. A., …, & Karolinska KI/K COVID-19 Study Group (2024). Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19. The Journal of Infectious Diseases, 230(2), e318-e326. https://doi.org/10.1093/infdis/jiae036
Vancouver
Strunz B, Maucourant C, Mehta A, Wan H, Du L, Sun D, et al. Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19. The Journal of Infectious Diseases. 2024;230(2):e318-e326. doi:10.1093/infdis/jiae036
BibTeX
@article{Strunz2024,
author = {Strunz, Benedikt and Maucourant, Christopher and Mehta, Adi and Wan, Hui and Du, Likun and Sun, Dan and Chen, Puran and Nordlander, Anna and Gao, Yu and Cornillet, Martin and Bister, Jonna and Kvedaraite, Egle and Christ, Wanda and Klingström, Jonas and Geanon, Daniel and Parke, Åsa and Ekwall-Larson, Anna and Rivino, Laura and MacAry, Paul A and Aleman, Soo and Buggert, Marcus and Ljunggren, Hans-Gustaf and Pan-Hammarström, Qiang and Lund-Johansen, Fridtjof and Strålin, Kristoffer and Björkström, Niklas K and Karolinska KI/K COVID-19 Study Group, Karolinska KI/K COVID-19 Study Group},
title = {Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {2},
pages = {e318--e326},
doi = {10.1093/infdis/jiae036}
}
EUVIMED